New in 2008!
No registration fee for this symposium!
Up to 6 CME hours available for this symposium!
Clonality Assessment in Hematopathology:
European and North American Perspectives
Special One-Day Symposium
October 29, 2008, 9:00am - 5:30pm

Symposium Sponsored by InVivoScribe™ Technologies, An AMP Silver Corporate Partner


Moderators:
Iris Schrijver, MD, Stanford University School of Medicine, Stanford, CA, USA
James L. Zehnder, MD, Stanford University School of Medicine, Stanford, CA, USA

Ig/TCR gene rearrangements and their usage in clonality testing: the Biomed-2 consortium effort
Jacques J.M. van Dongen, MD, PhD, Erasmus MC, The Netherlands

A practical approach to diagnostic clonality assessment in clinical pathology
Patricia Groenen, PhD, Radbout University Nijmegen MC, Nijmegen, The Netherlands

Technical pitfalls and interpretation of clonality testing challenges
Anton W. Langerak, PhD, Erasmus MC, The Netherlands

How does assay design affect results? Comparison of the Biomed-2 T gamma primers with a laboratory developed one-tube method.
Timothy C. Greiner, MD, University of Nebraska Medical Center, Omaha, NE, USA

Interpretation of T cell receptor gamma gene rearrangements by capillary electrophoresis based on normal distribution
Frank C. Kuo, MD, PhD, Brigham & Women's Hospital, Boston, MA, USA

T-cell clonality analysis in dermatopathologic disorders: from clonal patterns in reactive conditions to increased specificity with two different skin sites in suspected mycosis fungoides
Janis Taube, MD, Stanford Medical Center, Stanford, CA, USA

Panel and Case Discussions (All Speakers)